Juan Garcia Puebla, MD
Pulmonary Disease · Caguas, PRNPI 1689021727
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.2% of the total across 142 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by GSK at 27.8% of the total.
Across 142 payments — averaging $32.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$1K
- AstraZeneca$773
- Bayer$368
- Johnson & Johnson$347
- Sanofi$261
- Boehringer Ingelheim$251
- plus $1K from 19 others
What the payments were for
- Food & beverage$4,44797%
- Education$802%
- Gifts$501%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 40 | $1,274 |
| AstraZeneca | 26 | $773 |
| Bayer | 4 | $368 |
| Johnson & Johnson | 10 | $347 |
| Sanofi | 10 | $261 |
| Boehringer Ingelheim | 10 | $251 |
| Genentech USA, Inc. | 5 | $221 |
| Chiesi USA, Inc. | 6 | $143 |
| Merck | 4 | $139 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $124 |
| Shire North American Group Inc | 1 | $98 |
| Sanofi-aventis U.S. LLC | 2 | $93 |
| Amgen | 3 | $66 |
| Actelion Pharmaceuticals US, Inc. | 2 | $57 |
| Pfizer | 2 | $52 |
| United Therapeutics Corporation | 2 | $50 |
| AbbVie | 2 | $43 |
| Mallinckrodt Hospital Products Inc. | 1 | $38 |
| Olympus Latin America, Inc. | 1 | $32 |
| Mylan LLC | 1 | $28 |
| Mylan Specialty L.p. | 1 | $27 |
| ANI Pharmaceuticals, Inc. | 1 | $25 |
| Eli Lilly Export S.A. Puerto Rico Branch | 1 | $25 |
| Liquidia Technologies, Inc. | 1 | $23 |
| Viatris Specialty LLC | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRELEGY ELLIPTA$372
- Adempas$249
- DALIRESP$120
- NUCALA$100
How this compares
$4,577 in reported general payments places this provider in the 70th percentile of 138 pulmonary disease providers in Puerto Rico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Caguas
- Arnulfo Santana SantanaCaguas$6K
- Rosangela Fernandez MederoCaguas$5K
- Carissa Cruz BerriosCaguas$4K
- Jose Valles QuinonesCaguas$3K
- Alvaro Aranda RodriguezGuaynabo$725K
- Luis Garcia BarretoCoamo$393K
- Luis Nieves GarrasteguiRio Piedras$121K
- Jahaira Serrano DominguezArecibo$102K
- William Villanueva-BosqueArecibo$67K
- Domingo Chardon FelicianoPonce$45K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.